• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Race or genetic makeup for hepatitis C virus treatment decisions?

作者信息

O'Brien Thomas R, Kottilil Shyam, Feld Jordan J, Morgan Timothy R, Pfeiffer Ruth M

机构信息

Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD.

出版信息

Hepatology. 2017 Jun;65(6):2124-2125. doi: 10.1002/hep.29057. Epub 2017 Apr 18.

DOI:10.1002/hep.29057
PMID:28100007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5444941/
Abstract
摘要

相似文献

1
Race or genetic makeup for hepatitis C virus treatment decisions?丙型肝炎病毒治疗决策应考虑种族或基因构成因素吗？
Hepatology. 2017 Jun;65(6):2124-2125. doi: 10.1002/hep.29057. Epub 2017 Apr 18.
2
Impact of IL28B SNPs on therapeutic outcome and liver histology differs between hepatitis C virus genotypes.白细胞介素28B单核苷酸多态性对治疗结果和肝脏组织学的影响在丙型肝炎病毒基因型之间存在差异。
Pharmacogenomics. 2012 Jun;13(8):847-9. doi: 10.2217/pgs.12.57.
3
Treatment of hepatitis C virus genotype 1-infected patients: mission accomplished?丙型肝炎病毒1型感染患者的治疗：任务完成了吗？
Liver Int. 2016 Feb;36(2):181-4. doi: 10.1111/liv.13040.
4
[Physiopathology of HCV infection].[丙型肝炎病毒感染的病理生理学]
Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B154-62.
5
Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.根据白细胞介素 28B 基因型，不同分布的丙型肝炎病毒基因型在急性和慢性丙型肝炎感染 HIV 的患者中。
HIV Med. 2011 Sep;12(8):487-93. doi: 10.1111/j.1468-1293.2011.00912.x. Epub 2011 Mar 6.
6
Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.伊朗地中海贫血患者中人类白细胞抗原 II 类等位基因与丙型肝炎病毒清除和持续感染的关联。
J Med Virol. 2015 Sep;87(9):1565-72. doi: 10.1002/jmv.24211. Epub 2015 May 12.
7
Genotype distribution of hepatitis C virus in the Hungarian population with chronic viral hepatitis C.匈牙利慢性丙型病毒性肝炎患者群体中丙型肝炎病毒的基因型分布
Eur J Gastroenterol Hepatol. 2003 Apr;15(4):449-50. doi: 10.1097/00042737-200304000-00021.
8
Hepatitis C virus infection: when is a cure not a cure?丙型肝炎病毒感染：何时治愈并非真正治愈？
J Infect Dis. 2014 Jan 1;209(1):6-8. doi: 10.1093/infdis/jit543. Epub 2013 Oct 14.
9
[Genomic variability and natural history of hepatitis C virus infection].[丙型肝炎病毒感染的基因组变异性与自然史]
Gastroenterol Hepatol. 2002 Oct;25(8):514-20. doi: 10.1016/s0210-5705(02)70303-8.
10
[Difficulties for the detection of multiple genotypes of hepatitis C virus].[丙型肝炎病毒多种基因型检测的困难]
Medicina (B Aires). 2007;67(1):96-8.

引用本文的文献

1
IFNL4 genotype and other personal characteristics to predict response to 8-week sofosbuvir-based treatment for chronic hepatitis C.IFNL4 基因型和其他个体特征预测慢性丙型肝炎 8 周索磷布韦治疗的应答。
J Infect. 2024 Nov;89(5):106258. doi: 10.1016/j.jinf.2024.106258. Epub 2024 Aug 30.
2
In search of a function for human type III interferons: insights from inherited and acquired deficits.探索人类 III 型干扰素的功能：遗传性和获得性缺陷的启示。
Curr Opin Immunol. 2024 Apr;87:102427. doi: 10.1016/j.coi.2024.102427. Epub 2024 May 22.
3
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus.口腔拭子即时检测在丙型肝炎病毒直接作用抗病毒药物时代对 IFNL4 基因型的应用价值。
PLoS One. 2023 Jan 23;18(1):e0280551. doi: 10.1371/journal.pone.0280551. eCollection 2023.
4
Polymorphism as a Predictor of Sustained Virological Response to Sofosbuvir-Based Therapy for Hepatitis C Virus Patients.多态性作为丙型肝炎病毒患者基于索磷布韦治疗持续病毒学应答的预测指标
Trop Med Infect Dis. 2022 Sep 5;7(9):230. doi: 10.3390/tropicalmed7090230.
5
Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals.丙型肝炎病毒感染肝细胞中的干扰素反应：直接作用抗病毒药物时代需要考虑的问题。
Int J Mol Sci. 2020 Apr 8;21(7):2583. doi: 10.3390/ijms21072583.
6
Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials.丙型肝炎病毒1型感染黑人受试者使用直接作用抗病毒药物的持续病毒学应答率：临床试验的系统分析
J Virus Erad. 2019 Sep 18;5(3):138-144. doi: 10.1016/S2055-6640(20)30043-1.
7
What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?从 IFN-λ 变异体和丙型肝炎病毒感染的研究中我们学到了什么？
J Interferon Cytokine Res. 2019 Oct;39(10):618-626. doi: 10.1089/jir.2019.0048. Epub 2019 Jun 4.
8
Meeting Overview: Interferon Lambda-Disease Impact and Therapeutic Potential.会议概述：干扰素 λ-疾病影响和治疗潜力。
J Interferon Cytokine Res. 2019 Oct;39(10):586-591. doi: 10.1089/jir.2019.0018. Epub 2019 Apr 17.
9
The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets.缩短丙型肝炎治疗方案对固定预算下人群健康的影响
Open Forum Infect Dis. 2017 Dec 8;5(1):ofx267. doi: 10.1093/ofid/ofx267. eCollection 2018 Jan.
10
IFNL4 Genotype Is Associated With Virologic Relapse After 8-Week Treatment With Sofosbuvir, Velpatasvir, and Voxilaprevir.IFNL4基因分型与索磷布韦、维帕他韦和伏西瑞韦治疗8周后的病毒学复发相关。
Gastroenterology. 2017 Dec;153(6):1694-1695. doi: 10.1053/j.gastro.2017.06.069. Epub 2017 Nov 3.

本文引用的文献

1
The association between race/ethnicity and the effectiveness of direct antiviral agents for hepatitis C virus infection.种族/族裔与丙型肝炎病毒感染直接抗病毒药物疗效之间的关联。
Hepatology. 2017 Feb;65(2):426-438. doi: 10.1002/hep.28901. Epub 2016 Dec 24.
2
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.来迪派韦和索磷布韦用于治疗合并感染HIV-1的丙型肝炎病毒患者。
N Engl J Med. 2015 Aug 20;373(8):705-13. doi: 10.1056/NEJMoa1501315. Epub 2015 Jul 21.
3
Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis.索磷布韦与利迪帕韦治疗基因 1 型丙型肝炎病毒感染合并代偿性肝硬化患者的安全性和疗效综合分析。
Hepatology. 2015 Jul;62(1):79-86. doi: 10.1002/hep.27826. Epub 2015 May 9.
4
Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis C.慢性丙型肝炎患者对 ledipasvir/sofosbuvir 治疗 8 周的应答存在亚组差异。
Open Forum Infect Dis. 2014 Dec 13;1(3):ofu110. doi: 10.1093/ofid/ofu110. eCollection 2014 Dec.
5
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.IFNL3（IL28B）上游的一种变体创造了一个新的干扰素基因 IFNL4，与丙型肝炎病毒清除能力受损有关。
Nat Genet. 2013 Feb;45(2):164-71. doi: 10.1038/ng.2521. Epub 2013 Jan 6.